Lista de obras - Massimo Bertinaria - Dominio Público Uruguay

A new class of NO-donor H3-antagonists

artículo científico publicado en 2004

A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity

artículo científico publicado en 2009

A rapid screening for cytochrome P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives

artículo científico publicado en 2012

Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria

artículo científico publicado en 2011

Amphiphilic NO-Donor Antioxidants

artículo científico publicado en 2007

Anti-Helicobacter pylori agents endowed with H2-antagonist properties.

artículo científico publicado en 2001

Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties

scientific article published on 01 January 2000

Carnosine analogues containing NO-donor substructures: synthesis, physico-chemical characterization and preliminary pharmacological profile

artículo científico publicado en 2012

Corrigendum: Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors

scholarly article by Massimo Bertinaria et al published 26 November 2012 in ChemMedChem

Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors

artículo científico publicado en 2016

Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors

artículo científico publicado en 2016

Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitors

artículo científico publicado en 2012

Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease.

artículo científico publicado en 2017

Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity

scientific article published on 16 November 2018

Edaravone derivatives containing NO-donor functions

artículo científico publicado en 2009

Effect of the leaving group on the electrodic reduction mechanism of anti-Helicobacter pylori metronidazole derivatives, in aprotic and protic media.

artículo científico publicado en 2004

Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis

artículo científico publicado en 2014

Evidence of self-protonation on the electrodic reduction mechanism of an anti-Helicobacter pylori metronidazole isotere

Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives

artículo científico publicado en 2005

Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.

artículo científico publicado en 2008

NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties

scientific article published on 01 May 2006

Nitric Oxide Donor β2-Agonists: Furoxan Derivatives Containing the Fenoterol Moiety and Related Furazans

artículo científico publicado en 2007

Non-imidazole histamine NO-donor H3-antagonists

artículo científico publicado en 2005

Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents.

artículo científico publicado en 2013

Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by Alpha-Ketoglutarate and TET-TDG Functional Reactivation.

artículo científico publicado en 2017

Structure-antioxidant activity relationships in a series of NO-donor phenols

artículo científico publicado en 2008

Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds

Synthesis and antimalarial activities of some furoxan sulfones and related furazans.

artículo científico publicado en 2005

Synthesis, Physicochemical Characterization, and Biological Activities of New Carnosine Derivatives Stable in Human Serum As Potential Neuroprotective Agents

artículo científico publicado en 2010

Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades

scientific article published on 03 August 2020

[3-(1H-imidazol-4-yl)propyl]guanidines containing furoxan moieties: a new class of H3-antagonists endowed with NO-donor properties

artículo científico publicado en 2003

α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.

artículo científico publicado en 2018

Lista de obras de Massimo Bertinaria

A new class of NO-donor H3-antagonists

A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity

A rapid screening for cytochrome P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives

Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria

Amphiphilic NO-Donor Antioxidants

Anti-Helicobacter pylori agents endowed with H2-antagonist properties.

Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties

Carnosine analogues containing NO-donor substructures: synthesis, physico-chemical characterization and preliminary pharmacological profile

Corrigendum: Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors

Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors

Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors

Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitors

Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease.

Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity

Edaravone derivatives containing NO-donor functions

Effect of the leaving group on the electrodic reduction mechanism of anti-Helicobacter pylori metronidazole derivatives, in aprotic and protic media.

Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis

Evidence of self-protonation on the electrodic reduction mechanism of an anti-Helicobacter pylori metronidazole isotere

Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives

Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.

NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties

Nitric Oxide Donor β2-Agonists: Furoxan Derivatives Containing the Fenoterol Moiety and Related Furazans

Non-imidazole histamine NO-donor H3-antagonists

Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents.

Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by Alpha-Ketoglutarate and TET-TDG Functional Reactivation.

Structure-antioxidant activity relationships in a series of NO-donor phenols

Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds

Synthesis and antimalarial activities of some furoxan sulfones and related furazans.

Synthesis, Physicochemical Characterization, and Biological Activities of New Carnosine Derivatives Stable in Human Serum As Potential Neuroprotective Agents

Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades

[3-(1H-imidazol-4-yl)propyl]guanidines containing furoxan moieties: a new class of H3-antagonists endowed with NO-donor properties

α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.